CRISPR-based Gene Editing Market Report 2024-2030, Featuring Revvity, Danaher, GenScript, Merck, Tocris Bioscience, OriGene Technologies, Bio-Rad Laboratories, Bio-Techne & New England Biolabs
Investors in Bio-Rad Laboratories (NYSE:BIO) Have Unfortunately Lost 55% Over the Last Three Years
Bio-Rad Laboratories (BIO) Is a Classic Ariel Stock: Ariel Fund
Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024
Single-cell Technologies Research Report 2023-2024 & 2029 10x Genomics, Agilent Technologies, BD, Bio-Rad Laboratories, Danaher, Illumina, Merck, Promega, Qiagen, & Thermo Fisher Scientific - ResearchAndMarkets.com
Analysts Offer Insights on Healthcare Companies: Xencor (XNCR), Argenica Therapeutics Ltd (AU:AGN) and Bio-Rad Laboratories (BIO)